Drugs for Life

DrugsForLife-Dumit-Cover-rev

How Pharmaceutical Companies Define Our Health (2012 Duke University Press)

Kindle version is now out!

Hear my radio interview about Drugs for Life on BBC 4 Thinking Allowed

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, I consider how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, I attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry’s literature regarding strategies to expand markets for prescription drugs. I concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that it will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.

Here is introduction to it: Dumit 2012 Drugs for Life – Introduction

Buy Drugs for Life at Amazon

Drugs for Life also featured in Booktivism at the wonderful and scary Selling Sickness conference in February 2013. You can download a reader’s guide to the books here.

--

2012

Dumit, Joseph. 2012. Drugs for Life: Growing Health through Facts and Pharmaceuticals. Durham: Duke University Press.

»The Biomarx Experiment

PillDollar

“We want to maximize the number of new prescriptions…” “We want to identify people at risk at the earliest possible point…” Pharmaceutical marketers want to maximize the number of prescriptions in order to maximize profits. They see clinical trials as investments whose purpose was to increase sales of medicines, “Important clinical studies to conduct from Continue reading…

+
-

»How I Read

desk-bridge

Notes on reading modes sent to a grad class: I wanted to respond to the questions raised during our class regarding what kind of a reading I have been doing over these weeks.  I see it as close (as opposed to general), constructive (as opposed to deconstructive), positive (as opposed to negative), generous (as opposed Continue reading…

+
-

»Biomedicine as Culture

Biomedicine as Culture

Co-edited with Regula Burri in 2008. Biomedicine as Culture: Instrumental Practices, Technoscientific Knowledge, and New Modes of Life (Routledge Studies in Science, Technology and Society), best described through contents: Introduction REGULA VALÉRIE BURRI AND JOSEPH DUMIT PART I Social and cultural studies of biomedicine 1 Medicalizing culture(s) or culturalizing medicine(s) STEFAN BECK 2 Metaphors of medicine Continue reading…

+
-